Alexa Fluor® 647 anti-mouse CD206 (MMR) Antibody

Pricing & Availability
Clone
C068C2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype
Rat IgG2a, κ
a-C068C2_AF647_1_082911
Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) Alexa Fluor® 647 (top) or rat IgG2a, κ Alexa Fluor® 647 isotype control (bottom).
  • a-C068C2_AF647_1_082911
    Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) Alexa Fluor® 647 (top) or rat IgG2a, κ Alexa Fluor® 647 isotype control (bottom).
  • b-C068C2_AF647_2_082911
  • c-C068C2_A647_CD206_Antibody_3_120420
    C57BL/6 mouse frozen lymph node section was fixed with 4% paraformaldehyde (PFA) for 10 minutes at room temperature and blocked with 5% FBS plus 5% rat serum for 1 hour at room temperature. Then the section was stained with 5 µg/mL of CD206 (clone C068C2) Alexa Fluor® 647 (red), 5 µg/mL of CD3 (clone 145‐2C11) Alexa Fluor® 488 (green), and 5 µg/mL of B220 (clone RA3‐6B2) Alexa Fluor® 594 (blue) overnight at 4°C. The image was captured by 10X objective.
Compare all formats See Alexa Fluor® 647 spectral data
Cat # Size Price Quantity Check Availability
141711 25 µg $129.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
141712 100 µg $293.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC, IHC-F - Verified
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per million cells in 100 µL volume. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 5.0 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 647 has a maximum emission of 668 nm when it is excited at 633 nm / 635 nm.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Application References

(PubMed link indicates BioLegend citation)
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
  4. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  5. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Chandran S, et al. 2020. Front Immunol. 11:787. PubMed
  2. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  3. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  4. Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed
  5. Graça FA, et al. 2023. Nat Commun. 14:2900. PubMed
  6. El-Naccache DW, et al. 2022. Cell Rep. 40:111150. PubMed
  7. Draijer C, et al. 2023. Front Immunol. 13:1056477. PubMed
  8. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  9. Deville S, et al. 2022. Int J Mol Sci. 24: . PubMed
  10. Yang L, et al. 2023. Sci Rep. 13:1827. PubMed
  11. Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed
  12. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  13. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  14. Barkaway A, et al. 2021. Immunity. . PubMed
  15. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  16. Song Y, et al. 2013. Eur J Pharmacol. 705:49. PubMed
  17. Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
  18. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  19. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  20. Tang E, et al. 2015. J Lipid Res. 56:358. PubMed
  21. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  22. Helsley RN, et al. 2020. eLife. 8:e49882.. PubMed
  23. Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed
  24. Sato H, et al. 2020. Cell Reports. 31(5):107579. PubMed
  25. Howell KL, et al. 2021. FASEB J. 35:e21618. PubMed
  26. Chen L, et al. 2020. J Exp Med. 217:00:00. PubMed
  27. Calvo-Barreiro L, et al. 2021. Neurotherapeutics. . PubMed
  28. Xu Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  29. Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed
  30. Lee DY, et al. 2020. Chonnam Med J. 56:12:00. PubMed
  31. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  32. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  33. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  34. Enam SF, et al. 2020. J Neuroinflammation. 0.845138889. PubMed
  35. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  36. Garre JM, et al. 2020. Nat Commun. 11:1784. PubMed
  37. Herrada AA, et al. 2022. Front Immunol. 13:841641. PubMed
  38. De Simone G, et al. 2021. Immunity. :. PubMed
  39. Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed
  40. Blriot C, et al. 2021. Immunity. :. PubMed
  41. Ren Y, et al. 2020. Stem Cell Res Ther. 0.743055556. PubMed
  42. Wang H, et al. 2016. PLoS One. 11:e0167307. PubMed
  43. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  44. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  45. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  46. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  47. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  48. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  49. Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed
  50. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  51. Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed
  52. Gao L, et al. 2021. Exp Ther Med. 22:1367. PubMed
  53. Put S, et al. 2013. J Nucl Med. 54:807. PubMed
  54. Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
  55. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  56. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  57. Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
  58. Li H, et al. 2018. Nat Commun. 9:272. PubMed
  59. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  60. De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed
  61. Eixarch H, et al. 2020. Neurotherapeutics. 17:1988. PubMed
  62. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  63. Chakraborty A, et al. 2021. Biomaterials. 273:120796. PubMed
RRID
AB_10900240 (BioLegend Cat. No. 141711)
AB_10900240 (BioLegend Cat. No. 141712)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org
Go To Top Version: 6    Revision Date: 12/04/2020

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account